News

Filter news by
Record number of ETH spin-offs
In 2020, 34 spin-offs were founded at ETH Zurich, despite the coronavirus crisis. This is a new record. Many operate in the areas of artificial intelligence and sustainability. ETH spin-offs raised more than 400 million Swiss francs in capital overall.
AI helps compute turbulence
The modelling and simulation of turbulent flows is crucial for designing cars or predicting the weather. ETH Zurich has now successfully applied artificial intelligence to compute turbulence. This was done on the supercomputer “Piz Daint”.
Arvelle Therapeutics agrees sale
Zug - Arvelle Therapeutics is being taken over by the Italian firm Angelini Pharma for a price of 960 million US dollars. The start-up is developing an epilepsy drug. Angelini Pharma intends to open an affiliate in Switzerland by the end of 2022.  
Staffcloud used to organize vaccination personnel
Glattbrugg ZH – The Staffcloud software developed by Smartbridge is being used to support vaccination rollout. The software allows staff deployment to be planned, managed and budgeted across three Swiss cantons and Germany’s largest federal state.  
RAD offering new building module for cancer centers
Lugano - RAD Technology Medical Systems is expanding its portfolio of modular building systems for radiation therapy. The units have been designed for the latest models of linear accelerators. This means that patients can be treated just one month following the start of construction.  
Sustainable Nespresso capsules
The industrial group Dätwyler has agreed an extension of its partnership with Nespresso until 2030. Dätwyler will be investing in the expansion of its production processes based in the Greater Zurich Area with the aim of manufacturing more sustainable coffee capsules.
Oysho relying on textile technology from the Greater Zurich Area
Wollerau SZ – The Spanish clothing retailer Oysho is developing a collection of ski thermals together with the textile technology company X-Bionic from the canton of Schwyz. This collection uses X-Bionic’s patented technologies.  
SEBA Bank raises 20 million Swiss francs
Zug - The crypto bank SEBA has raised 20 million Swiss francs in a funding round, gaining new investors from Europe and Asia in the process. The new money is to be used to accelerate growth in Switzerland and abroad.
Biolytix does coronavirus testing
Witterswil SO - Biolytix AG specializes in microbiological and molecular biological investigations on plants and foodstuffs. In the midst of the coronavirus pandemic, however, the company has taken its first steps into a new business area. Biolytix is now responsible for carrying out coronavirus testing on behalf of major companies including Roche and Novartis.  

Meet with an expansion expert

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line. 

+41 44 254 59 59
info@greaterzuricharea.com